GMED - Globus Medical
$64.72 0.36 (0.56%)
Updated: 22:44 May 10, 2024 ESTNext Hour's AI Forecast
N/A
Avg. Accuracy (AI)
N/A
Next Session's AI Forecast
N/A
Avg. Accuracy (AI)
N/A
Next Week's AI Forecast
N/A
Trend's Accuracy (AI)
N/A
| Rank (0-100) |
| Rank (0-100) |
| Curr. Week | Curr. Month | Curr. Quarter | Next Quarter | Curr Year | 0 | -0.45 | -0.05 | 0.14 | -0.05 |
|---|
CURRENT VOLATILITY RANK
Variation from the lowest to the highest value in a period.
| Curr. Week | Curr. Month | Curr. Quarter | Next Quarter | Curr Year | 0 | 0.97 | 1.23 | 1.32 | 1.33 |
|---|
STOCHASTIC METRIC
The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.
| Curr. Week | Next Week | Curr. Month | Curr. Quarter | 100% | 100% | 100% | 100% |
|---|
MOVING AVERAGE METRIC
| 5 Sessions | Change 5 Sessions | 20 Sessions | Change 20 Sessions | 50 Sessions | Change 50 Sessions | 200 Sessions | 63.6 | 18.83% | 53.52 | 1.63% | 52.66 | 2.35% | 51.45 |
|---|
RSI METRIC
| RS Hour | RSI Hour | RS Day | RSI Day | 1.58 | 74.23 | 4.69 | 61.24 |
|---|
Globus Medical Technical Analysis News
Mentions in the news over the last three days
In the last three days Globus Medical was mentioned 2 times in 1 different publications.
GMED or PEN: Which Is the Better Value Stock Right Now?
"Currently, both Globus Medical and Penumbra are holding a Zacks Rank of # 2 (Buy). Investors should feel comfortable knowing that both of these stocks have an improving earnings outlook since the Zacks Rank favors companies that have witnessed positive analyst estimate revisions. But this is only part of the picture for value investors.", "Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED Quick QuoteGMED - Free Report) and Penumbra (PEN Quick QuotePEN - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look."
At May 9, 2024, 3:40 pm
Zacks
Globus Medical
2560 General Armistead Avenue
Audubon, PA 19403
United States
610 930 1800
https://www.globusmedical.com
Description
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Corporate Governance
Globus Medical, Inc.’s ISS Governance QualityScore as of January 28, 2023 is 10. The pillar scores are Audit: 8; Board: 9; Shareholder Rights: 10; Compensation: 6.
List of holders with stock participation in Globus Medical.
| Holder Rank | Holder | Shares | Date Reported | % Out | Value |
|---|